YNS-99671-96320
4 vaccinations
4 coded responses
42 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 472 / IN
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Pfizer-BioNTech
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
- 2021-04-09
-
2021-04-16
Dose 2 — Pfizer-BioNTech
- 2021-04-16
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-19
Survey response — days 1–6 daily, dose 2MedDRA: Heavy menstrual bleeding — Feeling: GoodFree text: Prolonged menstrual period (I average 3.5 days, this is day 7 but seems to be waning.)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Survey response — days 1–6 daily, dose 2MedDRA: Abnormal menstrual clots, Heavy menstrual bleeding, Muscle spasms — Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activitiesFree text: SEVERE - debilitating - Extremely heavy extended period bleeding, large clots, menorrhagic flow, cramps.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-21
- 2021-04-22
- 2021-04-23
-
2021-04-30
Survey response — day 14, dose 2MedDRA: Heavy menstrual bleeding — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Just one week after my period ended (and it was 10 days long and very heavy when normally it is 3.5), I have started another menstrual period with abnormally heavy bleeding.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-07-16
- 2021-10-15
-
2021-10-21
Dose 3 — Pfizer-BioNTech
- 2022-04-16
-
2022-04-25
Dose 4 — Pfizer-BioNTech
- 2022-04-25
- 2022-04-26
- 2022-04-27
- 2022-04-28
- 2022-04-29
- 2022-04-30
- 2022-05-01
- 2022-05-04
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-05-30
- 2022-06-06
- 2022-07-25
-
2022-10-27
Survey response — 6 months, dose 4MedDRA: Bursitis, Office visit, Periarthritis, Physiotherapy, Rotator cuff syndrome — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Frozen shoulder or rotator cuff tendinitis/bursitis · Healthcare visit (other): Orthopedic specialist visit and physical therapyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-27
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-10-28
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech | |
| 3 | 2021-10-21 | Pfizer-BioNTech | No |
| 4 | 2022-04-25 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-27 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Prolonged menstrual period (I average 3.5 days, this is day 7 but seems to be waning.)
Systemic reaction (other): SEVERE - debilitating - Extremely heavy extended period bleeding, large clots, menorrhagic flow, cramps.
Release 8 — day 14, dose 2
Symptoms: Just one week after my period ended (and it was 10 days long and very heavy when normally it is 3.5), I have started another menstrual period with abnormally heavy bleeding.
Release 12 — 6 months, dose 4
Symptoms: Frozen shoulder or rotator cuff tendinitis/bursitis
Healthcare visit (other): Orthopedic specialist visit and physical therapy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Physiotherapy | · | · | ✓ |
| SD | Bursitis | · | · | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Periarthritis | · | · | ✓ |
| SD | Rotator cuff syndrome | · | · | ✓ |
| SRO | Abnormal menstrual clots | ✓ | ✓ | ✓ |
| SRO | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release